ObjectiveTo evaluate for increases in the use and costs of respiratory viral testing in pediatric emergency departments (EDs) due to the COVID-19 pandemic. MethodsWe performed a cross-sectional study using the Pediatric Health Information System. Eligible subjects were children (90 days-18 years) who were discharged from a pediatric ED included in PHIS from October 2016 through March 2024. To evaluate for changes in the frequency and costs of respiratory viral testing, we performed an interrupted time series analysis across three study periods: pre-pandemic (October 1, 2016 to March 14, 2020), early pandemic (March 15, 2020 to December 31, 2023), and late pandemic (January 1, 2023 to March 31, 2024). ResultsWe included 15,261,939 encounters from 34 pediatric EDs over the 90-month study period. At least one viral respiratory test was performed for 460,826 of 7,311,177 pre-pandemic encounters (6.3%), 1,240,807 of 5,100,796 early pandemic encounters (24.3%), and 545,696 of 2,849,966 late pandemic encounters (19.1%). There was a positive pre-pandemic slope in viral testing (0.17% encounters/month; 95% confidence interval [CI] 0.17, 0.18). The early pandemic was associated with a shift change of 4.98% (95% CI 4.90, 5.07) and positive slope (0.54% encounters/month; 95% CI 0.54, 0.55). The late pandemic period was associated with a negative shift (-17.80%, 95% CI -17.90, -17.70) and positive slope (0.42% encounters/month; 95% CI 0.41, 0.42). The slope in testing costs increased from $5,000/month (95% CI $4,200, 5,700) to $33,000/month (95% CI $32,000, $34,000) during the early pandemic. ConclusionRespiratory testing and associated costs increased during the COVID-19 pandemic and were sustained, despite decreasing incidence of disease. These findings highlight a need for further efforts to clarify indications for viral testing in the ED and efforts to reduce low-value testing.
Read full abstract